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Introduction: Asthma control is considered the major goal of asthma management, while many
determinants of control are difficult to modify. We studied the association between respiratory
infection episodes (RTIs) of various types and asthma control.
Methods: Cross-sectional data were used from children aged 4e18 years with physician-
diagnosed asthma who participated in a web-based electronic portal for children with asthma,
allergies or infections. Asthma control was measured using the Childhood Asthma Control Test
(C-ACT) or the Asthma Control Test (ACT). Linear regression was used to analyse the associa-
tion between categories of numbers of various types of RTIs sustained in the preceding 12
months (categorized) and asthma control, adjusted for potential confounders.
Results: Asthma control was assessed in 654 children, and 68.5% were clinically well controlled
(ACT  20). Higher total numbers of RTIs in the last 12 months were strongly associated with a
lower level of asthma control (ptrend < 0.001). Similarly strong statistically significantChildren’s Hospital/University Medical Center Utrecht, Department of Paediatric Pulmonology and
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Respiratory tract infections and asthma control in children 1447associations were found for subtypes of RTI: 4 vs. 0 otitis episodes: coefficient 1.7 (95% CI
3.3 to 0.2); 5 vs.0 colds: coefficient 2.3 (95% CI 3.0 to 1.6); 3 vs. 0 bronchitis ep-
isodes: coefficient 3.1 (95% CI 4.0 to 2.3), each with ptrend < 0.05.
Conclusion: Higher numbers of reported respiratory tract infections are associated with lower
level of asthma control. The different type of respiratory tract infections contribute equally to
less controlled asthma.
ª 2014 Elsevier Ltd. All rights reserved.Introduction
Asthma is the most prevalent chronic disease in childhood.
International guidelines focus on asthma control as a
therapeutic goal [1]. Various studies report that asthma
control can be achieved for a majority of patients receiving
appropriate asthma therapy [2e4], yet poor asthma control
remains a large problem in the developed world. During
wheezing episodes, viruses are found in approximately 80%
of school-aged children [5]. Many studies have shown that
upper respiratory tract infections (URTI) can trigger asthma
exacerbations [6e8], but there is limited information about
the association between the frequency of upper and lower
respiratory tract infections and the impact on asthma
control in children.
Several other factors have been associated with lower
asthma control in children; e.g. older age [9], and the fe-
male sex [10e12], medication adherence [4,10,13], to-
bacco smoke exposure [10,14,15], and increased body mass
in boys [16e19]. Furthermore, allergic co-morbidity has
been described as a determinant of poor asthma control
[20,21], with eczema being associated with uncontrolled
asthma during autumn and winter, and allergic rhinitis
during spring and summer [22]. In general, asthma control
is best during summer, and lowest during autumn and spring
[22].
Poorly controlled asthma increases the risk for exacer-
bations [23]. In children, severe asthma exacerbations are
often preceded by upper respiratory tract infections
[6e8,24,25]. Despite the established relation between
acute viral infections and exacerbations, solid evidence on
the role of numbers of URTIs and lower respiratory tract
infections (LRTIs) on longer term asthma control is lacking.
We investigated if a higher number of RTI episodes in the
last 12 months was related to impaired asthma control. We
assessed the relative roles of URTIs (otitis, colds) and LRTIs
(bronchitis) in asthma control.Methods
Study population
Within a nationwide collaborative network of Dutch care-
givers, children presenting with asthma symptoms at the
outpatient department were included from June 2011 to
June 2013 [26]. In addition, children from the PACMAN
cohort study, identified via a pharmacy network that
received at least 3 prescriptions for asthma medication inthe last 2 years were included [27]. From those, patients
that were diagnosed with asthma, and completed the
Asthma Control Test (ACT), were selected for further ana-
lyses. Asthma was defined as a doctors’ diagnosed asthma,
based on the ERS/ATS guidelines [1]. Parents gave informed
consent for participation, and the medical ethics commit-
tee of the University Medical Centre Utrecht approved the
study.Electronic portal
Questionnaires were filled in by each patient or parents on
a personal page within an Electronic Portal (EP). This web-
based application contains health- and disease-related
questions on respiratory- and allergic diseases, as well as
questionnaires about exposures and demographic informa-
tion. Information about current asthma symptoms was
adopted from the ISAAC questionnaire. Detailed informa-
tion about asthma control, treatment and adherence were
obtained [26]. Medication adherence was measured by
using the Medication Adherence Report Scale (MARS)
comprising five questions on medication use behaviour [28].
Patients with a MARS score 20 were considered to be
adherent [29].
The number of LRTIs was defined as the answer to the
question: ‘how many bronchitis episodes (Zcoughing,
dyspnoea and fever) did your child experience in the last 12
months?’ URTIs were divided into otitis episodes and colds;
the number of otitis episodes was defined as the answer to
the question ‘how many otitis episodes (Zearache, otor-
roea, fever) did your child experience in the last 12
months?’ and for colds as: ‘how many cold-episodes
(Zblocked nose, running nose and coughing), did your
child experience in the last 12 months?’. As ages of all
children ranged between 4 and 18 years, anthropometric
measurements were transformed into z-scores.Asthma control
Asthma control was measured using the Childhood Asthma
Control Test (C-ACT) for children 4e11 years old [30] or the
Asthma Control Test (ACT) for children 12 years and older
[31]. For each patient, the total score was calculated
ranging from 0 to 27 for the C-ACT and from 5 to 25 for the
ACT, with a score below 20 indicates inadequately
controlled asthma for both age categories. The ACT score as
hereafter used in this article refers to the combination of
ACT and C-ACT score.
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Medication use was categorized into the treatment steps
that are described in the Dutch guidelines [32]. Patients
are stepped up in treatment when there is insufficient
response to the current treatment step, despite sufficient
adherence. Step 1 consists of Short-Acting Beta-Agonists
(SABA); Step 2 adds inhalation corticosteroids (ICS) in start
dosages (Beclomethasone twice daily 200 mg or equiva-
lent). Step 3, ICS dosage is doubled or Long-Acting Beta-
Agonists (LABA). Leukotriene Receptor Antagonists (LTRA)
may be an alternative to LABA. Step 4/5 consists of double
dosages of ICS (as compared to step 3) while LABA or LTRA
are continued.Figure 1 Proportion of patients with experiencing otitis ep-
isodes, colds or bronchitis episodes in the last 12 months
(n Z 465).Atopic co-morbidity
Parent reported rhinitis was defined as yes to the ques-
tion: ‘In the past 12 months, has your child had a problem
with sneezing or a runny or blocked nose when he/she did
not have a cold or the flu?‘; Parent reported eczema was
defined as yes to the question ‘Has your child had an
itchy rash (which was coming and going) at any time in
the last 12 months?’, and parent reported food allergy
was defined as yes to the question ‘does your child have a
food allergy, or do you suspect your child to have a food
allergy?’. Atopic co-morbidity was defined as present if
one of the three above questions were answered
positive.Figure 2 Proportion of patients with any otitis episode, cold
or bronchitis episode, or a combination of those in the last 12
months (n Z 455). C Z Cold; B Z Bronchitis; O Z Otitis.Statistical analysis
Descriptive analyses, including means and standard de-
viations (SD) or medians and interquartile ranges (IQR), and
proportions were performed to describe the study
population.
As the C-ACT and ACT differ in range (0e25 and 0e27),
the ACT score was standardized by calculating z-scores in
order to analyse whether the association between de-
terminants and ACT score differed from the association
between determinants and the standardized ACT score. As
we found no differences, further analyses were performed
using the ACT score as outcome parameter. To avoid bias
that might result from a complete case analysis, missing
data were imputed by using multiple imputations. First,
known determinants of asthma control were described by
tertiles of numbers of RTIs, to assess potential confounding
as input for main analyses. As gender and age, current
smoke exposure and treatment are clearly related to both
number of RTIs [14,33] and asthma control [10,14,34],
these were taken as a basic confounder set .We performed
trend tests over categories of numbers of RTI by adding
category indicators as continuous independent variables to
the models.
Finally, as allergic sensitization increases risk for a se-
vere RTI [7,24,25], we explored if allergic sensitization
modified our associations of interest testing for interaction.
As asthma control varies by season [22], and prevalence of
RTIs shows seasonality [24], we similarly tested for inter-
action by the season. Statistical analysis was performedusing IBM SPSS statistics version 20.0 (Armonk, New York,
USA).
Results
Physician-diagnosed asthma was present in 654 children.
Sixty-two percent were male, and the mean age was 10.1
years (SD 3.5). Participants were predominantly of western
origin (82.7%). The median ACT-score was 21 (IQR 18e24),
and 68.5% of all asthmatic children were well controlled
(ACT score  20). Most patients experienced 1 or more
respiratory tract infections in the last 12 months (n Z 455
(69.6%)). The proportion of patients experiencing RTIs,
categorized by otitis, cold and bronchitis episodes are
shown in Fig. 1. Fig. 2 shows the proportional overlap in
Respiratory tract infections and asthma control in children 1449patients experiencing bronchitis, cold and/or otitis
episodes.
Determinants of asthma control by tertiles of numbers
of RTIs are shown in Table 1. Younger age, western
ethnicity, and presence of allergic rhinitis or atopic co-
morbidity in general, were all significantly associated
with a higher number of RTIs. Furthermore, a higher
asthma treatment step was associated with a higher num-
ber of RTIs.
In the univariable analysis, (Table 2), experiencing 5 or
more colds, or any bronchitis episode were both signifi-
cantly associated with less asthma control as compared to
no RTI episodes. There was no interaction with seasonal or
allergic co-morbidity and number of RTIs.
When accounting for confounding in multivariable ana-
lyses, higher numbers of RTIs remained significantly asso-
ciated with less asthma control (p-value for trend <0.001).
Less asthma control was associated with more otitis epi-
sodes (ptrend 0.015); more colds (ptrend 0.001) and more
bronchitis episodes (ptrend 0.006) (Table 2).
With standardized regression coefficients, associations
with subtypes of RTI showed trends with similar strengths
over categories; otitis 0.14 (95%CI 0.23 to 0.05); colds
0.13 (95% CI 0.20 to 0.05), bronchitis 0.11 (95% CI
0.19 to 0.03).Table 1 Predictors of asthma control by increasing tertiles of n
N (%) Lowe
(n Z
Gender (male) 409 (62.5) 129
Age (years) 10.1 (3.5) 10.9
Ethnicity (Western)a 541 (82.7) 159
Height (z-score) 0.1 (4.0) 0.25
to 0.
Weight (z-score) 0.7 (7.6) 0.18
to 0.
Maternal education (high) 291 (44.5) 98
Smoking by one of the parents (y) 52 (8.0) 18
Co-morbidity (last 12 months)
Allergic rhinitis (y) 498 (76.1) 138
Eczema skin rash (y) 282 (43.1) 76
Food allergy (suspected) 308 (47.1) 90
Atopic co-morbidity
(any of the above)
563 (86.1) 164
Summer 168 (25.7) 49
Autumn 137 (20.9) 41
Winter 140 (21.4) 43
Spring 209 (32.0) 70
Therapy step-up plan
0 No medication use 58 (8.9) 25
1 SABA only 60 (9.2) 22
2 ICS medium dose (þSABA) 237 (36.2) 66
3 ICS high dose or LABA/LTRA
medium dose (þICS any dose)
171 (26.1) 42
4/5 LABA/LTRA (þhigh dose ICS) 129 (19.7) 49
Adherent to medication use (y) 471 (72.0) 70
Data are n (%), n/N (%), Mean (SD) or median (IQR). IQR Z Interquar
Bold data are significantly related to the outcome, p < 0.05.
a Ethnicity: Western (North America, Australia and Europe, except T
defined according to CBS-Definition on www.cbs.nl; p-values from treDiscussion
This study shows that an increased number of upper res-
piratory tract infections in the last 12 months, namely 4
otitis episodes, 5 colds as well as any bronchitis episode
are associated with less asthma control. It also shows that a
rather large proportion of children have uncontrolled
asthma (31.5%).
As asthma control is an important risk factor for an
asthma exacerbation [23], it is important to obtain and
maintain asthma control. Previous studies have shown that
respiratory tract infections play a key role in asthma ex-
acerbations [6,8]. However, to date no specific treatments
are available to significantly alter the clinical outcome of
viral infections in asthmatic children. Several therapeutic
strategies have been considered; however, results are
disappointing due to virus specificity [5], side effects, and
need for administration early in the course of the infection.
Glucocorticosteroids are by far the most widely used drugs
in asthma treatment, and have potent anti-inflammatory
activity. The use of inhaled steroids, which was 82.1% in
our study population, did not lead to the prevention of
respiratory tract infections, which occurred in 71.2%. This
may possibly be due to medication adherence, as lowumbers of respiratory tract infections (n Z 654).
st tertile
203)
Middle tertile
(n Z 229)
Highest tertile
(n Z 222)
p-value
(63.5) 84 (36.7) 88 (39.6) 0.76
(3.0) 10.1 (3.4) 9.3 (3.9) <0.001
(78.7) 199 (86.9) 183 (82.4) 0.007
(0.75
82)
0.11 (0.88
to 0.97)
0.18 (0.99
to 0.81)
0.48
(0.85
83)
0.07 (0.85
to 0.81)
0.11 (0.77
to 0.70)
0.43
(48.3) 104 (45.4) 89 (40.1) 0.24
(8.9) 21 (9.2) 13 (5.9) 0.33
(68.0) 176 (76.9) 184 (82.9) 0.002
(37.4) 101 (44.1) 105 (47.3) 0.13
(44.3) 108 (47.2) 109 (49.1) 0.62
(80.8) 199 (86.9) 200 (90.1) 0.030
(24.1) 66 (28.8) 54 (24.3) 0.57
(20.2) 41 (17.9) 55 (24.8)
(21.2) 48 (21.0) 50 (22.5)
(19.7) 75 (32.8) 64 (28.8)
(12.3) 16 (7.0) 18 (8.1) 0.005
(10.8) 25 (10.9) 13 (5.9)
(32.5) 95 (41.5) 76 (34.2)
(20.7) 53 (23.1) 77 (34.7)
(24.1) 41 (17.9) 38 (17.1)
(34.5) 101 (44.1) 119 (53.6) 0.33
tile range.
urkey) and Non-Western (South America, Caribbean, Africa, Asia)
nd tests over tertiles.
Table 2 The association between respiratory tract infections in the last 12 months and the asthma control test score.a
Number of: Number (%) Model 1 Model 2 p-trend
Regression coefficient 95% CI p-value Regression coefficient 95% CI p-value
Total RTI episodes
0 195 (29.8) Ref e Ref e
1e7 257(39.3) L0.89 (L1.65 to L0.14) <0.001 L0.79 (L1.52 to L0.07) 0.032 <0.001
8 202 (30.9) L3.41 (L4.21 to L2.62) <0.001 L3.20 (L3.99 to L2.41) <0.001
Otitis episodes
0 547 (83.6) Ref e Ref e
1e3 73 (11.2) 0.95 (2.00 to 0.10) 0.054 0.70 (1.72 to 0.33) 0.181 0.015
4 34 (5.2) 1.50 (3.02 to 0.03) 0.077 L1.73 (L3.26 to L0.20) 0.027
Colds
0 293 (44.8) Ref e Ref e
1e4 156 (23.8) 0.62 (1.14 to 0.18) 0.129 0.51 (1.27 to 0.25) 0.190 0.001
5 205 (31.3) L2.54 (L3.28 to L1.80) <0.001 L2.27 (L2.98 to L1.55) <0.001
Bronchitis episodes
0 441 (67.4) Ref e Ref e
1e2 158 (24.2) L1.46 (L2.21 to L0.70) <0.001 L1.40 (L2.13 to L0.67) <0.001 0.006
3 55 (8.4) L3.21 (L4.07 to L2.35) <0.001 L3.14 (L4.01 to L2.26) <0.001
Model 1 Z Univariable association between each type of RTI and asthma control.
Model 2 Z model 1 þ gender, age, ethnicity, smoke exposure and treatment regimen.
Bold data are significantly related to the outcome, p < 0.05.
a Higher scores indicates better asthma control.
1450 K. Zomer-Kooijker et al.adherence may lead to lower asthma control. However, in
contrast to many previous studies [4,10,13], we found no
association between medication adherence and the level of
asthma control. This may be due to the method of
measuring medication adherence [35], however, this
parent-reported medication method has been shown to be
a reliable tool to assess medication adherence.
We did not find interaction between the presence of
atopic co-morbidity and number of RTI’s. Previous studies
have found that atopy (defined by the presence of sensiti-
zation) was associated with more severe illness and loss of
control in asthmatic children [7,24,25]. Instead of atopy, we
used the presence of atopic morbidity, defined as the pres-
ence of at least one of the following atopic diseases: food
allergy, eczema or allergic rhinitis. This different definition
may explain why the interaction was not found. However,
this same study [24] did also show that there was no differ-
ence in the number of (viral) illnesses or infection rates in
sensitized children as compared to non-sensitized children.
As we have studied the number of RTI episodes and not the
severity of the episodes, this may also explain differences.
We did not find interaction between season and the number
of RTIs. This may be due to the fact that we assessed the
number of RTIs in the last 12 months, and did not have in-
formation about the number of infections per season.
The strength of this study is that it focuses on a het-
erogeneous group of asthmatic children, who were
recruited from both general practitioners and hospital
settings. All patients completed a broad questionnaire,
which enabled us to study a large number of factors, be-
sides RTIs, related to asthma control. However, some
methodological considerations should be made.First of all, the use of a cross-sectional study design to
investigate interrelationships among variables limited our
ability to study cause-and-effect relationships. It remains
uncertain whether a higher number of RTIs causes the lower
level of asthma control, orwhether the higher number of RTIs
are a result of lower level of asthma control. Longitudinal
studies are needed to confirm causality. However, in a large
meta-analysis in which the effect of inhaled steroids on res-
piratory tract infections was studied, it was shown that
treatment with inhaled steroids in children was associated
with lower number of pneumonias andupper respiratory tract
infections [36]. This might be the result of an improvement of
asthma control, and provides evidence for fact that lower
asthma control leads to a higher number of RTIs.
Secondly, selection bias may have played a role, due to
non-random missing values of participants not willing to
take the time to complete the questionnaire. However, we
have imputed missing values using multiple imputations,
the currently accepted best way to avoid bias resulting
from complete case analysis [37]. Thirdly, recall bias may
have led to underreporting of mild infections in well
controlled children.
Fourthly, no viral samples were available of the RTI
episodes in our patients, as patients were not seen by a
physician during most of the episodes. However, it is known
that in about 20% of wheezing episodes no virus is detected
[5]. Finally, due to the parent reported infections in chil-
dren, misclassification might have to overestimation of the
association between asthma control and the number of
infections. For instance, worsening of allergic rhinitis may
have been reported as a cold. This is less likely for bron-
chitis episodes, as the presence of fever was required to be
Respiratory tract infections and asthma control in children 1451classified as a bronchitis, but also those episodes were
parent-reported.
Viral respiratory tract infections are inherent to the
paediatric age; they occur frequently in early infancy
where viral pathogens are detected in up to 90% of the
symptomatic children. Furthermore, viral pathogens are
also frequently found (in about 40%) in young children
without respiratory symptoms [38]. School age children
may easily be infected by their younger siblings. Thera-
peutic or preventive strategies have shown to be ineffec-
tive in influencing the course of a respiratory tract infection
in children, or preventing asthma exacerbations [5,39,40].
As long as viral pathogens remain present in symptomatic
and asymptomatic children, it is unlikely that complete
asthma control will probably be achieved in all children.
In conclusion, our data suggest an association between a
higher number of RTI episodes and lower level of long term
asthma control in children. More otitis, cold or bronchitis
episodes contribute equally to less asthma control.
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